CRL 106.89 (+4.11%)
US1598641074• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. CRL

Charles River Laboratories (CRL) Stories

Here is a selected set of our story library related to Charles River Laboratories (CRL).

Post

Charles River Laboratories (CRL) - Piotroski F-Score Analysis for Year 2023 (Final Score: 6/9)

Charles River Laboratories (CRL) Piotroski F-Score Analysis for 2023: Final Score 6/9. Evaluate CRL's profitability, liquidity, and efficiency using 9 criteria.

2024-06-07